Oneview Healthcare PLC · ASX:ONE
Oneview Healthcare — H1 2020 Earnings Presentation
31 slides from Oneview Healthcare's earnings presentation, Aug 31, 2020
Slide 1: H1 2020 Interim Results
Oneview Healthcare Plc H1 2020 INTERIM RESULTS 31 August 2020
Slide 2: Legal disclaimer
Legal disclaimer This presentation contains general information about the activities of Oneview Healthcare PLC (ABRN 610 611 768) (Oneview or Company) which is current as at 31 August 2020. It is in summary form and does not purport to be complete. It presents financial information on a statutory ba
Slide 3: Agenda
AGENDA • Overview: Our solutions and business model • Company update: H1 2020 operational and financial Overview • Our strategy • Outlook • Financial statements 3
Slide 4: Our solutions and business model
Our solutions and business model 4 4
Slide 5: Our vision
Our vision To power personalised, exemplary care experiences. 5
Slide 6: Problems we’re solving
Problems we’re solving Patients, families and care IT teams want technology Oneview has solved these teams need a better care that is built for the problems for leading experience; this means enterprise: a reliable, healthcare systems across higher satisfaction, higher flexible, scalable platform th
Slide 7: Our solution
Our solution Our Care Experience Platform unifies systems, data, organisations and people – to improve outcomes, quality & value 7
Slide 8: The patient view
The patient view Unit 1 Unit 2 Unit 3 Unit 4 Unit 5 Unit 6 Personalised for patients Engaging and informing 8
Slide 9: The care team view
The care team view Oneview Hospital Unit 1 Unit 2 Unit 3 Unit 4 Unit 5 Unit 6 Self-service operational insight Driving care team workflow 9
Slide 10: Our business model
Our business model Subscription-based software (per bed, Long-term contracts (3-5 years) per day) Expand ACV with healthcare Provision of proprietary hardware enterprises through additional beds and up-selling Oneview & partner Professional services solutions Strong market opportunity with bedside t
Slide 11: Company Update – H1 2020 Summary
Company Update – H1 2020 Summary 11 11
Slide 12: H1 2020 Overview
H1 2020 Overview 30% YOY growth in • Expanded global footprint – live beds up 30% YOY to 9068 live beds up (to 9,068) • Recurring revenue up 21% to €2.6M, reflecting expanded user base • Short-term impact to total revenue as COVID-19 delayed Q2 • deployments 40-50% revenue growth expected in H2 (vs
Slide 13: COVID-19 impact
COVID-19 impact Sales momentum and Supply chain issues with Healthcare systems were implementations new hardware due to fully focused on delivery negatively impacted lockdown in China, now of care for COVID-19 resolved during the 2nd quarter Seamless transition to Worked with existing Healthcare sys
Slide 14: Success with marquee healthcare systems
Success with marquee healthcare systems New contract wins and extensions across key accounts Since June 30th in target markets: • Signed Oklahoma University Hospital (new client) • Central Acute Services Building (NSW Health) • First Purchase Order received from NSW Health for • Contract renewal at
Slide 15: H1 2020 Financial Highlights
H1 2020 Financial Highlights H1-20 H1-19 Variance • Growth in recurring revenue: 21% Recurring revenue growth €M €M (H120 – H19) negatively impacted in the half by the impact of the Covid- 19 pandemic which restricted our ability to proceed with a Recurring revenue 2.6 2.1 +21% number of scheduled d
Slide 16: Annualised recurring revenue growth
Annualised recurring revenue growth €6.m 10,000 €5.1m 9,000 €4.9m €5.m €4.5m 8,000 €4.3m 7,000 €4.m €3.4m 6,000 €3.m 5,000 €2.5m €2.2m 4,000 €2.m €2.m 3,000 €1.2m €.9m 2,000 €1.m 1,000 1,294 1,671 2,666 3,000 3,582 5,228 6,258 6,976 8,535 9,068 €.m - IPO Jun-16 Dec-16 Jun-17 Dec-17 Jun-18 Dec-18 Jun
Slide 17: Refocused & driving down costs
Refocused & driving down costs Refocused on our core revenue generating product Successful offshoring diversification of engineering resources Headcount reduced by 60% from peak (2018) Overall OpEx down by 38% YOY 17
Slide 18: Business pipeline
Business pipeline 42 35,000 Opportunities in 11,882 €7.6m 35,981 CRM Beds in active ARR Total beds in 30,000 pipeline opportunity enterprise 15,030 25,000 13,376 20,000 • Significant YOY growth in Live Beds – Despite the installation schedule being impacted COVID-19 in Q2. Hardware supply chain impa
Slide 19: Our strategy
Our strategy Onéview>,
Slide 20: Growth strategy
Growth strategy Make it faster, easier, Make our platform more lower cost for customers valuable by enhancing Reduce operational to implement and the value proposition complexity operate New capabilities and Standardise customers on Lower-cost hardware and partnerships (e.g. virtual Next Generation
Slide 21: COVID-19: Accelerating cloud
COVID-19: Accelerating cloud CUSTOMER NEEDS RESPONDING ACCELERATING Needed reliable video at the Formed a cross-functional Demonstrated the power of bedside team to deliver a “slice” of the cloud to enable agility and Oneview platform in the cloud reduce the overhead of Oneview staff unable to go on
Slide 22: Faster, easier, lower cost: cloud
Faster, easier, lower cost: cloud Now Q1 2021 Q2 2021 Cloud Cloud Start Cloud Enterprise Advance Unit / Hospital Hospital Enterprise Android Tablets Android Tablets / TV / AIO Android Tablets / TV / AIO Not integrated Simple integration Full integration Apps, games, content, + TV, service requests +
Slide 23: Positioned for growth with next gen platform
Positioned for growth with next gen platform Built for the enterprise Modern micro-service with better scalability architecture: foundation and stability for cloud All-in-One (AIO) Purpose-built OEM hardware provides Android platform means extended device 60-70% lower-cost lifecycles, hardware hardw
Slide 24: Enhancing the value of the platform
Enhancing the value of the platform Virtual Patient Partnerships Care Feedback • The Android platform enables • Scaling telehealth at the • Patient experience is key to us to deliver partner solutions bedside is now a focus for improving the quality of care, • We have seen how quickly we healthcare
Slide 25: Standardise our customer base
Standardise our customer base The completion of our hardware suite will enable us to standardise our customer base on new hardware 2,921 beds Next Gen Working with customers to plan migrations aligned to hardware 32% refreshes, moving to Android hardware 6,147 beds Gen 2 (Legacy) Proprietary Android
Slide 26: H2 Outlook
H2 Outlook • Scheduled projects pointing to revenue growth of 40-50% in H2 vs H1 • Management is continuing to examine the cost base with a determination to more closely align fixed costs with 2021expected recurring revenues • Delivery of WeTek set top box in September will enable expansion business
Slide 27: Financial Statements
27 Financial Statements Oneview>,,
Slide 28: H1 2020 Income Statement
H1 2020 Income Statement • Recurring revenue increase of 21% due to increase in live beds in the US, Australia and Thailand • Sales of hardware and services (non-recurring revenue) reduced by 69% due to the impact of the Covid-19 pandemic which restricted our ability to proceed with a number of sche
Slide 29: H1 2020 Balance Sheet
H1 2020 Balance Sheet • Cash balance of €5.1m • Only debt is PPP loan in US, which is likely to be forgiven under the "CARES" Act 29
Slide 30: H1 2020 Cash Flow
H1 2020 Cash Flow • Net cash at 30 June 2020 of €5.1m • Total operating cash outflow of €5.1m, down 8% on the pcp. • Tight cost control initiatives implemented in late 2019, combined with restructuring in early 2020, result in significantly reduced operating expenses • Cash burn lower due to reduced
Slide 31: Unifying the care experience.
Unifying the care experience.